Closed allaway closed 4 years ago
Self assigning this to add it to the heterogeneity section.
My read is that the takeaway recommendation is that trying multiple methods is the safest bet, rather than relying on one method. It's a bit of an assumption on my part that this rule of thumb would apply to all rare disease applications as well, but I think this is a reasonable (and conservative) assumption.
@jaybee84 made a comment on #44 (that ended up going unaddressed) about whether we could provide some criteria or a rule of thumb for selecting dimensionality reduction methods.
This paper from @cgreene and others seems like it would be relevant to address this idea :)
Compressing gene expression data using multiple latent space dimensionalities learns complementary biological representations https://doi.org/10.1186/s13059-020-02021-3